Exhibit 10.47
[E XECUTION C OPY ]
SETTLEMENT AGREEMENT AND MUTUAL
GENERAL RELEASE
1. Parties . The parties to
this Settlement Agreement and Mutual General Release
(“Agreement”) are:
(a) Orange 21 Inc. (“Orange
21”), Spy Optic, Inc. (“Spy Optic”), Spy S.r.l
(“Spy Italy”) and LEM S.r.l. (“LEM”).
Orange 21, Spy Optic, Spy Italy and LEM are collectively referred
to herein as the “Orange 21 Parties”;
(b) Mark Simo (“Simo”);
Simo Holdings, Inc. (fka No Fear, Inc.) (“No Fear”); No
Fear Retail Stores, Inc. (“No Fear Retail”); and MX No
Fear Europe SAS (“MX No Fear Europe”). Simo, No Fear,
No Fear Retail and MX No Fear Europe are collectively referred to
herein as the “No Fear Parties”).
(c) The Orange 21 Parties and the No
Fear Parties are sometimes collectively referred to herein as the
“Parties.”
2. Effective Date . The
Effective Date of this Agreement is April 28, 2009 (the
“Effective Date”).
3. The Dispute . A dispute
has arisen between the Parties relating to their respective rights
and obligations arising out of various business transactions
including, without limitation, Simo’s service as Chief
Executive Officer of Orange 21, the purchase of goods by No Fear
from Spy Optic, and the purchase of goods by MX No Fear Europe from
Spy Italy.
4. Monetary Payment
.
(a) On the Effective Date, No Fear
shall pay to Orange 21, in federal funds, by wire transfer to an
account to be designated in advance by Orange 21, an amount in U.S.
Dollars equivalent to Three Hundred Seven Thousand, Four Hundred
Fourteen and Eighty One Hundredths Euros (€307,414.81). For
purposes of this payment, the exchange rate for Euros to Dollars
has previously been determined and agreed to. These funds will be
applied to fully satisfy the outstanding amount Spy Italy claims to
be owed by MX No Fear Europe.
1 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
(b) In addition, on the respective
Due Dates set forth in the table below, No Fear will make the
following monetary payments in federal funds to Orange 21 or its
designee by wire transfer to an account designated by Orange 21
prior to the Effective Date, or to such other accounts as Orange 21
may designate in writing thereafter:
|
|
|
|
Due Date
|
|
Amount of Payment
|
|
Effective
Date
|
|
Seventy-One
Thousand Four Hundred Eighty Nine and Thirty-Two Hundredths U.S.
Dollars ($71,489.32)
|
|
|
|
One
(1) month following the Effective Date
|
|
Seventy-One
Thousand Four Hundred Eighty Nine and Thirty-Two Hundredths U.S.
Dollars ($71,489.32)
|
|
|
|
Two
(2) months following the Effective Date
|
|
Seventy-One
Thousand Four Hundred Eighty Nine and Thirty-Two Hundredths U.S.
Dollars ($71,489.32)
|
|
|
|
Three
(3) months following the Effective Date
|
|
Seventy-One
Thousand Four Hundred Eighty Nine and Thirty-Two Hundredths U.S.
Dollars ($71,489.32)
|
|
|
|
Four
(4) months following the Effective Date
|
|
Seventy-One
Thousand Four Hundred Eighty Nine and Thirty-Two Hundredths U.S.
Dollars ($71,489.32)
|
|
|
|
Five
(5) months following the Effective Date
|
|
Seventy-One
Thousand Four Hundred Eighty Nine and Thirty-Two Hundredths U.S.
Dollars ($71,489.32)
|
(c) If Orange 21 fails to timely
provide any credit required under Paragraph 5 in full when due, or
to apply any available credit to any purchase order that has been
accepted by Orange 21, and does not correct any such failure within
five business days of No Fear providing written notice of this
failure directed to Jerry Collazo, Chief Financial Officer, at
Orange 21 with a copy to Chris Forrester at Morrison &
Foerster, LLP, then No Fear shall have no obligation under this
Agreement to make any payments under this Paragraph 4 due after
such failure and notice, until such time as such credit is made
available and thereafter all obligations under this Paragraph 4
shall resume.
2 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
(d) Notwithstanding any other
provision herein to the contrary, in no event shall Orange 21 be
entitled to offset any amounts to be provided as credits to Simo
under Paragraph 5 by any payments to be made to No Fear under this
Paragraph 4.
5. Product Credits
.
(a) Provided that the payments set
forth above are made timely and in full in accordance with
Paragraph 4 and receipt of all such funds in full is confirmed by
Orange 21, Orange 21 shall provide Simo, or other No Fear Parties
as Simo may designate, with a credit in the aggregate amount of Six
Hundred Thousand U.S. Dollars ($600,000), less the Applicable
Withholding Amount (defined in Paragraph 8 below), to purchase
products from Orange 21 for retail resale to the public (which
products will be sold to Simo or his designee [CONFIDENTIAL
TREATMENT REQUESTED] as follows:
|
|
|
|
Date
|
|
Amount of Credit
|
|
Effective
Date
|
|
Three Hundred
Fifty Thousand U.S. Dollars ($350,000) less the Applicable
Withholding Amount
|
|
|
|
One
(1) month following the Effective Date
|
|
Fifty Thousand
U.S. Dollars ($50,000) less the Applicable Withholding
Amount
|
|
|
|
Two
(2) months following the Effective Date
|
|
Fifty Thousand
U.S. Dollars ($50,000) less the Applicable Withholding
Amount
|
|
|
|
Three
(3) months following the Effective Date
|
|
Fifty Thousand
U.S. Dollars ($50,000) less the Applicable Withholding
Amount
|
|
|
|
Four
(4) months following the Effective Date
|
|
Fifty Thousand
U.S. Dollars ($50,000) less the Applicable Withholding
Amount
|
|
|
|
Five
(5) months following the Effective Date
|
|
Fifty Thousand
U.S. Dollars ($50,000) less the Applicable Withholding
Amount
|
3 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
(b) The Orange 21 Parties shall use
commercially reasonable efforts to fill each purchase order
submitted by the No Fear Parties within a commercially reasonable
period after receipt (with delivery F.O.B. Spy Optic’s
Carlsbad, California facility); provided, however, that the Orange
21 Parties shall not be required to fill any purchase orders
submitted by the No Fear Parties which exceed the aggregate amount
of any existing credit balance pursuant to the credit schedule set
forth above; and provided further, however, that to the extent the
Orange 21 Parties do not fill any such purchase orders, the No Fear
Parties shall retain any unused or unapplied credit balance to
apply to any future purchase orders which do not exceed the amount
of their credit balance.
(c) The initial purchase order of
the No Fear Parties, which shall be submitted on the Effective
Date, shall be for products in the quantities and styles set forth
under the column titled “At Once” in Schedule 1
attached hereto, and all such products shall be delivered by Orange
21 on the Effective Date. Thereafter, the No Fear Parties will
order products and the Orange 21 Parties will deliver products
under this Paragraph 5 substantially in the quantities and styles
set forth in Schedule 1 attached hereto; provided, however, that if
at any time the Orange 21 Parties determine that it is or may
become commercially unreasonable or impracticable to fill any
purchase orders based on available inventory and other customer
orders, the Orange 21 Parties will promptly inform the No Fear
Parties, and the Parties will reasonably cooperate in making
adjustments to the products ordered by the No Fear Parties and to
be delivered by the Orange 21 Parties.
4 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
(d) If No Fear fails to timely make
any payment required under Paragraph 4 in full when due, then
Orange 21 shall have no further obligation under this Agreement to
provide any further product credits under this Paragraph 5 due
after such failure (including, without limitation the corresponding
credit to be given on the Date of such payment) until such time as
such payment is made.
(e) Notwithstanding any other
provision herein to the contrary, in no event shall the No Fear
Parties be entitled to offset any amounts payable by the No Fear
Parties to Orange 21 or its designee under Paragraph 4 by any
product credits extended to No Fear under this Paragraph
5.
6. Promissory Note . The
payments required in Paragraph 5 above shall be memorialized in a
promissory note in substantially the form attached hereto as
Exhibit A (the “Note”) from No Fear payable to Orange
21 or its designee, with the principal amount to be reduced by the
amounts of all payments made by No Fear to Orange 21 (or its
designee) pursuant to the schedule in Paragraph 4. The unpaid
principal amount due shall begin to bear interest at the rate of
ten percent, compounded annually, if No Fear fails to timely make
any payment when due as required under Paragraph 4.
7. Security for Payments .
The Note shall be secured by a pledge of Orange 21 held of record
or beneficially by No Fear, pursuant to a stock pledge agreement in
substantially the form attached hereto as Exhibit B, and all
certificates of ownership of any such stock under the Security
Agreement shall be delivered to the Orange 21 Parties by the No
Fear Parties along with the executed version of this Agreement, the
Promissory Note and the stock pledge agreement. The pledged stock
shall be valued at $0.80 per share for collateral purposes,
regardless of any then prevailing market price for the common stock
of Orange 21.
5 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
8. Income Tax . It is
understood and agreed that in connection with the transactions
contemplated hereby, Orange 21 will withhold approximately 33.72%
(the “Applicable Withholding Amount”) of the gross
amount of each credit as set forth in Paragraph 5 above as and when
granted to Simo or his designee, shall reduce each credit by the
Applicable Withholding Amount, and shall remit all such amounts to
the Internal Revenue Service and the Franchise Tax Board, as
applicable. Orange 21 will provide Simo with a W-2 form consistent
with the foregoing.
9. Product Purchase
Agreements . The Parties shall enter into product purchase
agreements in substantially the forms of Exhibits C-1 and C-2
attached hereto.
10. General Releases . The
Orange 21 Parties on the one hand, and the No Fear Parties on the
other, hereby release each other and their respective past, present
and future officers, employees, partners, shareholders,
subsidiaries, affiliates, predecessors, successors, assigns,
agents, representatives, insurers, and attorneys, from all claims,
whether past, present, or future, for all liability for any and all
damages or other relief, directly or indirectly arising from,
related to, or sustained by reason of any prior dealings of any
kind between them at any time. These releases include but are not
limited to a release by Simo of any and all claims arising out of
his service as the Chief Executive Officer of Orange 21 and any and
all claims by Simo or No Fear arising out of or related to their
ownership of stock or other securities of Orange 21. These general
releases specifically include, but are not limited to, a release
of
6 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
all claims for any expenses to which any Party
may have been or may be put, and also include all damages to any
Party, whether compensatory or punitive, and whether now known or
unknown. For the avoidance of doubt, the Parties agree that these
general releases do not release any party for liability in
connection with actions or events that occur after the Effective
Date of this Agreement.
11. Waiver of Civil Code
Section 1542 . All rights under Section 1542 of the
Civil Code of the State of California are hereby expressly waived
by all Parties with respect to any and all releases set forth
herein. It is understood that Section 1542 provides as
follows:
A general release does not extend to
claims which the creditor does not know or suspect to exist in his
or her favor at the time of executing the release, which, if known
by him or her, must have materially affected his settlement with
the debtor.
12. Notices . All notices and
other communications provided for hereunder shall, unless otherwise
stated herein, be in writing (including by facsimile) and mailed
(by certified or registered mail), sent or delivered as
follows:
|
|
|
|
|
|
If to any of
|
|
|
|
|
|
the Orange 21 Parties:
|
|
Orange 21
Inc.
|
|
|
|
|
Attention:
Chief Financial Officer
|
|
|
|
|
2070 Las Palmas
Drive
|
|
|
|
|
Carlsbad,
California 92011
|
|
|
|
|
Phone: (760)
804-8420
|
|
|
|
|
Fax: (760)
804-8440
|
|
|
|
|
|
|
With a copy
to:
|
|
Morrison &
Foerster LLP
|
|
|
|
|
Attention:
Christopher M. Forrester
|
|
|
|
|
12531 High
Bluff Drive
|
|
|
|
|
San Diego,
California 92130
|
|
|
|
|
Phone: (858)
720-5110
|
|
|
|
|
Fax: (858)
720-5125
|
|
|
7 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
|
|
|
|
|
|
If to any
of
|
|
|
|
|
|
the No Fear
Parties:
|
|
Simo Holdings,
Inc.
|
|
|
|
|
Attention:
Chief Executive Officer
|
|
|
|
|
1812 Aston
Avenue
|
|
|
|
|
Carlsbad,
California 92008
|
|
|
|
|
Phone: (760)
931-9550
|
|
|
|
|
Fax: (760)
931-9741
|
|
|
|
|
|
|
With a copy
to:
|
|
Reeder, Lu
& Green, LLP
|
|
|
|
|
Attention:
Gabriel G. Green
|
|
|
|
|
2121 Avenue of
the Stars, Suite 950
|
|
|
|
|
Los Angeles,
California 90067
|
|
|
|
|
Phone: (310)
270-9300
|
|
|
|
|
Fax: (310)
270-9311
|
|
|
or to such other address or
facsimile number as such party shall have designated in a written
notice to the other party. All such notices and communications
shall be effective (i) if delivered by hand, sent by certified
or registered mail or sent by an overnight courier service, when
received; and (ii) if sent by facsimile transmission, when
sent.
13. No Admission . This
Agreement is in compromise of disputed claims and is not an
admission of liability for all or any part of any such claims by
any Party.
14. Applicable Law . This
Agreement shall be governed by, construed and enforced in accord
with the laws of the State of California.
15. Jurisdiction to Enforce .
Any action to enforce, for breach of, or arising out of this
Agreement shall be commenced in the Superior Court for the State of
California, County of San Diego, and the Parties each agree and
consent to jurisdiction over them in that court for any such
proceeding.
16. Persons Bound and
Benefited . This Agreement shall be binding upon and inure to
the benefit of the Parties hereto, as well as all their
representatives, employees, principals, agents, assigns,
predecessors, successors, parents, affiliates, subsidiaries,
partners and investors, and insurers.
8 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
17. Integration . This
Agreement and the Exhibits attached hereto constitutes the entire
agreement between the Parties with respect to the settlement,
payment, dismissal, releases, and all other matters and terms
referenced herein. Without limiting the foregoing, the Parties
agree that in any dispute arising out of this Agreement, no
evidence relating to the negotiation or drafting of this Agreement,
or any prior drafts of this Agreement, shall be admissible as
evidence for any purpose, including but not limited to interpreting
this Agreement of the intention of the Parties.
18. Agreement Understood .
The Parties certify they have read all of this Agreement, consulted
with and received legal advice from their respective attorneys
concerning this Agreement, and understand and agree to the terms of
this Agreement.
19. Involvement of Counsel .
The Parties acknowledge they have been represented by legal counsel
of their choosing in the negotiation and drafting of the terms of
this Agreement, each Party enters into this Agreement of its own
volition, freely and without coercion, based on its own judgment
and advice of its own counsel, and not in reliance on any
representations or promises of the other Party except as expressly
set forth herein.
20. Joint Preparation . This
Agreement has been jointly negotiated and drafted, and is not to be
construed against any Party on the basis that it was the
drafter.
21. Authority . Each person
and party executing this Agreement warrants he or it is the sole
owner of the rights and obligations referred to and released
herein, has not assigned or otherwise transferred any interest in
any such rights or obligations, and is authorized to execute this
Agreement personally or on behalf of any entity for whom he or it
is acting.
9 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
22. Execution of Agreement .
This Agreement may be executed by separately signed signature
pages, and when so executed shall have the full force and effect as
if all Parties had signed a single original document.
23. Cooperation and Execution of
Additional Documentation . The Parties agree to cooperate and
execute additional documentation which may be required to
implement, memorialize or carry out the provisions and intent of
this Agreement.
24. Attorneys’ Fees and
Costs Resulting From Breach . If any Party incurs any
attorneys’ fees or costs as a result of another Party’s
breach of any obligation under this Agreement, the aggrieved Party
shall be entitled to recover all such attorneys’ fees and
costs incurred as a result of the breach.
|
|
|
|
|
|
|
|
|
|
APPROVED:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MORRISON &
FOERSTER LLP
|
|
|
|
|
|
Date:
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
|
Mark C.
Zebrowski
|
|
|
|
|
|
|
|
|
|
|
Attorneys for
the Orange 21 Parties
|
|
|
|
|
|
|
|
|
|
|
REEDER LU
GREEN, LLP
|
|
|
|
|
|
Date:
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
|
Gabriel G.
Green
|
|
|
|
|
|
|
|
|
|
|
Attorneys for
the No Fear Parties
|
10 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.
|
|
|
|
|
|
|
|
|
|
AGREED AND
ACCEPTED:
|
|
|
|
|
|
|
|
|
|
|
Date:
|
|
|
|
Orange 21
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Its:
|
|
|
|
|
|
|
Date:
|
|
|
|
Spy Optic,
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Its:
|
|
|
|
|
|
|
Date:
|
|
|
|
Spy
S.r.l.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Its:
|
|
|
|
|
|
|
Date:
|
|
|
|
LEM
S.r.l.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Its:
|
|
|
|
|
|
|
Date:
|
|
|
|
No Fear Retail
Stores, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Its:
|
|
|
|
|
|
|
Date:
|
|
|
|
MX No Fear
Europe SAS
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Its:
|
|
|
11 of 13
Information in this exhibit
marked [CONFIDENTIAL TREATMENT REQUESTED] has been omitted and will
be filed separately with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.
Confidential treatment has been requested with respect to the
omitted portions.